Cargando…
Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria
BACKGROUND: In Nigeria, private for-profit health facilities present an opportunity to achieve the UNAIDS 95-95-95 HIV targets because of their reach and patronage. However, little is known about determinants of outcomes in these facilities. This study describes patient outcomes and the patient and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864871/ https://www.ncbi.nlm.nih.gov/pubmed/35193597 http://dx.doi.org/10.1186/s12981-022-00438-3 |
_version_ | 1784655540254670848 |
---|---|
author | Aina, Muyi Yesufu, Zeena Salisu, Abdulateef Ezeanolue, Echezona Mensah, Charles Dakum, Patrick |
author_facet | Aina, Muyi Yesufu, Zeena Salisu, Abdulateef Ezeanolue, Echezona Mensah, Charles Dakum, Patrick |
author_sort | Aina, Muyi |
collection | PubMed |
description | BACKGROUND: In Nigeria, private for-profit health facilities present an opportunity to achieve the UNAIDS 95-95-95 HIV targets because of their reach and patronage. However, little is known about determinants of outcomes in these facilities. This study describes patient outcomes and the patient and health facility characteristics associated with these outcomes in adults receiving HIV treatment in private facilities in the Federal Capital Territory (FCT), Benue and Nasarawa states in north-central Nigeria. METHODS: A retrospective longitudinal analysis of program data collected between 2013 and 2019 was done. Patient attributes and outcomes were compared across the two states and FCT. Incidence rates were determined for all cause exit, mortality and loss to follow up (LTFU). Cox proportional hazard models were used to identify associations between patient and facility attributes and these outcomes. Bivariate and multivariate logistic regression models were used to determine the factors associated with viral suppression among the study participants. RESULTS: Of the 22,010 study subjects, 42.7%, 22.2% and 35.1%, respectively, were in Benue, FCT and Nasarawa. Almost a third (31.8%) had received antiretroviral treatment (ART) for less than a year at censoring. Incidence rates for all-cause exit, mortality and loss to follow up (LTFU) were 17.2 (95% CI 16.8, 17.5), 2.1 (95% CI 2.0, 2.2), and 11.2 (95% CI 10.8, 11.8) per 100 person years respectively. Males had higher risks of death (HR = 1.47, 95% CI 1.25–1.73), and LTFU (HR = 1.08, 95% CI 1.00–1.16). Age at ART start showed a dose–response association with both mortality and LTFU. Care at model facilities (OR = 2.16, p < 0.001), Zidovudine (AZT)-based regimens (OR = 2.00, p < 0.001), and lowest quartile baseline CD4 + count (OR = 2.40, p < 0.001) were associated with regimen switch. 75.6% of subjects were viral suppressed. Male gender (OR = 0.84, p = 0.025); AZT-based regimen (OR = 0.72, p < 0.001), age in the bottom quartile (OR = 0.71, p = 0.002) were associated with virally suppression. CONCLUSION: Private for-profit facilities are a major provider of HIV and other health services in Nigeria. With appropriate technical support and engagement, they can help accelerate efforts to achieve epidemic control of HIV in Nigeria, and contribute to achievement of UNAIDS 95-95-95 target by 2030. |
format | Online Article Text |
id | pubmed-8864871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88648712022-02-28 Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria Aina, Muyi Yesufu, Zeena Salisu, Abdulateef Ezeanolue, Echezona Mensah, Charles Dakum, Patrick AIDS Res Ther Research BACKGROUND: In Nigeria, private for-profit health facilities present an opportunity to achieve the UNAIDS 95-95-95 HIV targets because of their reach and patronage. However, little is known about determinants of outcomes in these facilities. This study describes patient outcomes and the patient and health facility characteristics associated with these outcomes in adults receiving HIV treatment in private facilities in the Federal Capital Territory (FCT), Benue and Nasarawa states in north-central Nigeria. METHODS: A retrospective longitudinal analysis of program data collected between 2013 and 2019 was done. Patient attributes and outcomes were compared across the two states and FCT. Incidence rates were determined for all cause exit, mortality and loss to follow up (LTFU). Cox proportional hazard models were used to identify associations between patient and facility attributes and these outcomes. Bivariate and multivariate logistic regression models were used to determine the factors associated with viral suppression among the study participants. RESULTS: Of the 22,010 study subjects, 42.7%, 22.2% and 35.1%, respectively, were in Benue, FCT and Nasarawa. Almost a third (31.8%) had received antiretroviral treatment (ART) for less than a year at censoring. Incidence rates for all-cause exit, mortality and loss to follow up (LTFU) were 17.2 (95% CI 16.8, 17.5), 2.1 (95% CI 2.0, 2.2), and 11.2 (95% CI 10.8, 11.8) per 100 person years respectively. Males had higher risks of death (HR = 1.47, 95% CI 1.25–1.73), and LTFU (HR = 1.08, 95% CI 1.00–1.16). Age at ART start showed a dose–response association with both mortality and LTFU. Care at model facilities (OR = 2.16, p < 0.001), Zidovudine (AZT)-based regimens (OR = 2.00, p < 0.001), and lowest quartile baseline CD4 + count (OR = 2.40, p < 0.001) were associated with regimen switch. 75.6% of subjects were viral suppressed. Male gender (OR = 0.84, p = 0.025); AZT-based regimen (OR = 0.72, p < 0.001), age in the bottom quartile (OR = 0.71, p = 0.002) were associated with virally suppression. CONCLUSION: Private for-profit facilities are a major provider of HIV and other health services in Nigeria. With appropriate technical support and engagement, they can help accelerate efforts to achieve epidemic control of HIV in Nigeria, and contribute to achievement of UNAIDS 95-95-95 target by 2030. BioMed Central 2022-02-22 /pmc/articles/PMC8864871/ /pubmed/35193597 http://dx.doi.org/10.1186/s12981-022-00438-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Aina, Muyi Yesufu, Zeena Salisu, Abdulateef Ezeanolue, Echezona Mensah, Charles Dakum, Patrick Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria |
title | Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria |
title_full | Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria |
title_fullStr | Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria |
title_full_unstemmed | Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria |
title_short | Patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in Nigeria |
title_sort | patient and health facility attributes associated with retention and virologic suppression in private for-profit health facilities in nigeria |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864871/ https://www.ncbi.nlm.nih.gov/pubmed/35193597 http://dx.doi.org/10.1186/s12981-022-00438-3 |
work_keys_str_mv | AT ainamuyi patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria AT yesufuzeena patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria AT salisuabdulateef patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria AT ezeanolueechezona patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria AT mensahcharles patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria AT dakumpatrick patientandhealthfacilityattributesassociatedwithretentionandvirologicsuppressioninprivateforprofithealthfacilitiesinnigeria |